Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857662 · ClinicalTrials.gov registry record · Phase 2
Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)
A Phase 2 study, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 117
- Enrollment target
NCT00857662 is a Phase 2 study that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 117 participants.
The verdict
NCT00857662, a Phase 2 study, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 117 participants
- Enrollment target
Study Summary
Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%
Interventions
- DEVICE Onyx
- DEVICE TRUFILL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2001-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00857662
The ClinicalTrials.gov registry entry for NCT00857662 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Onyx is the first listed.
NCT00857662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00857662 about?
NCT00857662 is a clinical study titled "Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)". Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%
What is the current status of trial NCT00857662?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 117 participants. The study started on 2001-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00857662?
The interventions under investigation include: Onyx (DEVICE), TRUFILL (DEVICE).
Who is sponsoring clinical trial NCT00857662?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.